Market Cap
$30.0B
GEHC
GE HealthCare Technologies Inc.
$63.98 ▼ -2.13%
Prev close $65.37Market cap$30.0B
ConsensusBuy
12-mo target$83.05 (+29.8%)
▲ Bullish
Analyst conviction 7/10
Insider Buying Cluster (7 insiders)High Impact Filing (7/10)30 New Institutional Positions20 Institutional ExitsCongressional Activity (3) Healthcare & Medical Devices
Snapshot
The big-picture read on GEHC right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (68%)
Inst. Holders
50 funds
Inst. Value
$20.6B
Inst. Activity
30 buys / 20 sells
Insider Activity
$6.4M buy / $0.00 sell
Insider Net $
$6.4M
Social Sentiment
61° Warm
SEC Reports
7
Congressional
8 trades
Price chart 30d -9.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: GEHC — 55.8% short (0.5M / 0.9M)
Short: 507,257 | Exempt: 23 | TRF Vol: 909,094 | Short Ratio: 55.8% | Off-exchange volume (dark pool
Sep 14, 2026 Insider
Grogan William K was granted 62,256 shares
Chief Financial Officer
Sep 14, 2026 Insider
Grogan William K was granted 12,840 shares
Chief Financial Officer
Sep 14, 2026 Insider
Grogan William K was granted 31,877 shares
Chief Financial Officer
Jul 30, 2026 Congress
Jul 29, 2026 SEC Ro Khanna buy
$1,001 - $15,000 — House
GE HealthCare filed an 8-K to disclose a change in its reportable segment structure, combining Imaging and Advanced Visu
8-K — Impact 2/10
Jul 7, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 — House
Jun 30, 2026 Inst.
NORGES BANK — NEW
5,823,524 shares ($372.8M)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
68% rate it Buy or better · 28 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 22, 2026 | Needham | INITIATE | Buy | 50% |
| Sep 17, 2026 | BTIG | REITERATE | Buy | 53% |
| Aug 19, 2026 | BTIG | REITERATE | Buy | 53% |
| Jul 31, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 30, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 30, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
| Jul 30, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Jul 29, 2026 | BTIG | MAINTAIN | Buy | 53% |
| Jul 17, 2026 | Hovde Group | INITIATE | Market Perform | 79% |
| Jul 16, 2026 | UBS | MAINTAIN | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 8 | 11 | 9 | 0 | 0 | 68% | |
| Aug 1, 2026 | 8 | 11 | 9 | 0 | 0 | 68% | |
| Jul 1, 2026 | 8 | 11 | 9 | 0 | 0 | 68% | |
| Jun 1, 2026 | 8 | 10 | 9 | 0 | 0 | 67% | |
| May 1, 2026 | 8 | 10 | 9 | 1 | 0 | 64% | |
| Apr 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% | |
| Mar 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% | |
| Feb 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% |
Price targets
Where 19 covering analysts think GEHC trades over the next 12 months.
$83.05 +29.8% upside Strong Buy
Current$63.98 Low$70.00 Median$84.00 High$96.00 19 analysts
$70.00$96.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +27.3%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
61°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 6 neutral · avg impact 3.1/10.
NEUTRAL8-K2/10
GE HealthCare filed an 8-K to disclose a change in its reportable segment structure, combining Imagi
Jul 29, 2026
NEUTRALCLUSTER2/10
Two independent directors made modest open-market purchases totaling $163K in GEHC, while the CEO of
May 19, 2026
NEUTRALCLUSTER4/10
GE HealthCare insiders, including director H. Lawrence Culp Jr. ($5.0M), CEO Peter Arduini ($250K),
May 12, 2026
NEUTRAL8-K2/10
GE HealthCare filed an 8-K reporting the results of its May 7, 2026 annual shareholder meeting and t
May 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: GEHC — 55.8% short (0.5M / 0.9M)
Short: 507,257 | Exempt: 23 | TRF Vol: 909,094 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: GEHC — 63.8% short (0.6M / 0.9M)
Short: 552,835 | Exempt: 1,017 | TRF Vol: 866,801 | Short Ratio: 63.8% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: GEHC — 60.1% short (0.7M / 1.2M)
Short: 699,805 | Exempt: 32 | TRF Vol: 1,164,134 | Short Ratio: 60.1% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: GEHC — 56.2% short (0.6M / 1.0M)
Short: 562,456 | Exempt: 1,720 | TRF Vol: 1,001,360 | Short Ratio: 56.2% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: GEHC — 74.4% short (1.0M / 1.4M)
Short: 1,044,329 | Exempt: 678 | TRF Vol: 1,404,058 | Short Ratio: 74.4% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.20 | $1.18–$1.25 | 12.5% | -0.0% | 0↑ 13↓ | $5.4B | 16 |
| Next Q | $1.59 | $1.48–$1.68 | 10.7% | -0.1% | 3↑ 9↓ | $5.9B | 15 |
| Current FY | $4.93 | $4.78–$5.00 | 7.3% | -0.0% | 15↑ 1↓ | $21.7B | 20 |
| Next FY | $5.41 | $4.92–$5.64 | 9.9% | +0.0% | 12↑ 4↓ | $22.7B | 20 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.204 | — |
| 7d ago | $1.204 | — |
| 30d ago | $1.204 | -0.000 |
| 60d ago | $1.204 | -0.000 |
| 90d ago | $1.244 | -0.040 |
Institutional ownership
Which big funds own GEHC (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $20.6B total value (321,212,599 shares) as of 2026-Q2. Top holders: DODGE, BlackRock,, VANGUARD. Net buying activity: 30 institutions added/increased vs 20 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| DODGE & COX | 37,864,164 | $2.4B | 11.8% | — |
| BlackRock, Inc. | 37,467,843 | $2.4B | 11.7% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 29,724,359 | $1.9B | 9.3% | — |
| STATE STREET CORP | 20,861,566 | $1.3B | 6.5% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 20,275,526 | $1.3B | 6.3% | — |
| Invesco Ltd. | 18,296,350 | $1.2B | 5.7% | — |
| HARRIS ASSOCIATES L P | 15,329,664 | $981.3M | 4.8% | — |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 13,455,814 | $861.3M | 4.2% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 12,871,800 | $820.8M | 4.0% | — |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 12,250,502 | $784.2M | 3.8% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 5,823,524 | — | $372.8M |
| GOLDMAN SACHS GROUP INC | ADD | 3,266,138 | 4,446,565 | +36.1% | $284.6M |
| Amundi | DOUBLED | 1,087,641 | 2,500,094 | +129.9% | $160.0M |
| DEUTSCHE BANK AG\ | ADD | 1,691,185 | 2,374,070 | +40.4% | $152.0M |
| CITADEL ADVISORS LLC | ADD | 1,293,268 | 2,367,032 | +83.0% | $151.5M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | ADD | 1,287,686 | 1,862,023 | +44.6% | $119.2M |
| UBS Group AG | TRIM | 2,805,315 | 1,529,542 | -45.5% | $97.9M |
| NewEdge Advisors, LLC | ADD | 877,072 | 1,318,329 | +50.3% | $84.4M |
| Point72 Asset Management, L.P. | DOUBLED | 125,069 | 1,165,973 | +832.3% | $74.6M |
| CANADA PENSION PLAN INVESTMENT BOARD | NEAR_EXIT | 4,978,835 | 1,106,134 | -77.8% | $70.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 50 transactions. Net $6.4M — $6.4M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Grogan William K | Chief Financial Officer | AWARD | 62,256 | — | — |
| Sep 14, 2026 | Grogan William K | Chief Financial Officer | AWARD | 12,840 | — | — |
| Sep 14, 2026 | Grogan William K | Chief Financial Officer | AWARD | 31,877 | — | — |
| Sep 3, 2026 | O'Neill Kevin Michael | CEO, PDx | TAX W/H | 718 | $70.56 | $50.7K |
| Sep 3, 2026 | Kass-Hout Taha | Chief Technology Officer | TAX W/H | 1,502 | $70.56 | $106.0K |
| Sep 3, 2026 | Newcomb George A. | Chief Accounting Officer | TAX W/H | 112 | $70.56 | $7.9K |
| Sep 3, 2026 | Estrampes Catherine | Chief Commer. & Growth Officer | TAX W/H | 508 | $70.56 | $35.8K |
| Sep 3, 2026 | Jimenez Frank R | GC & Corporate Secretary | TAX W/H | 1,480 | $70.56 | $104.4K |
| Sep 3, 2026 | Arduini Peter J | President and CEO | TAX W/H | 6,303 | $70.56 | $444.7K |
| Sep 3, 2026 | Rackliffe Philip | CEO, AIS | TAX W/H | 798 | $70.56 | $56.3K |
Congressional trades
GEHC trades disclosed by members of Congress, with disclosure delay.
3 members · 6 buys / 2 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Aug 12, 2026(14d) |
| Jul 7, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Aug 12, 2026(37d) |
| Jul 6, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Aug 12, 2026(38d) |
| Jul 2, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Aug 12, 2026(42d) |
| Jun 30, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Jul 8, 2026(9d) |
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | May 13, 2026(31d) |
| Mar 25, 2026 | Terri Sewell | D | HOUSE | SELL | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Apr 21, 2026(28d) |
| Mar 23, 2026 | Warren Davidson | R | HOUSE | SELL | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Mar 26, 2026(4d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for GEHC.
Shares short
16,909,543
Settlement Sep 15, 2026
Change vs prior
-10.8%
Semi-monthly cycle
Days to cover
5.5
At avg daily volume
Of shares outstanding
≈3.7%
Estimate — not % of float
All GEHC filing & press-release reports (7)
- 8-K reportJul 29, 2026
- CLUSTER reportMay 19, 2026
- CLUSTER reportMay 12, 2026
- 8-K reportMay 11, 2026
- CLUSTER reportMay 1, 2026
- 8-K reportApr 29, 2026
- DEFA14A reportMar 19, 2026